VANCOUVER, BC — January 2, 2026 — Leads & Copy — StickIt Technologies Inc. (CSE: STKT) has amended the terms of its common share consolidation, effective January 7, 2026, alongside an update to its post-consolidation private placement. The company, also known as STKT, is the parent company of StickIt Ltd., an Israeli technology and cannabinoid company that developed the patent-protected “Cannabis Sticks” technology.
The common shares of StickIt Technologies will be consolidated on a one-for-five basis. The record date for the consolidation is set for January 6, 2026. The company will maintain its existing stock symbol “STKT” on the CSE.
StickIt currently has 127,547,356 common shares issued and outstanding. Upon completion of the consolidation, the company will have 25,509,471 common shares issued and outstanding.
Fractional shares remaining after the consolidation will be canceled, with shareholdings rounded down to the nearest whole number. Outstanding stock options will be adjusted by the same consolidation ratio. The Board of Directors has the authority to implement the share consolidation via resolution and does not intend to seek shareholder approval.
The company also announced an amendment to its post-consolidation private placement of Units, for gross proceeds of not less than $700,000 and not more than $1,050,000 at $0.025 per Unit. Each Unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for three years from the issuance date into one additional common share upon payment of $0.025. The warrants cannot be exercised until the Company completes a further consolidation of its share capital, whereby every two (2) existing shares will be consolidated into one (1) new share. Finder’s fees will be paid in cash and securities according to CSE policies.
The CSE has granted StickIt Technologies approval to proceed with the private placement without securityholder approval, based on exceptions in section 4.6(2)(b) of CSE Policy 4, as the company faces serious financial difficulties. No related person of the company will participate in the private placement.
StickIt’s primary assets include patents and patent applications related to plant extracts, therapeutic compounds in smoking utensils, and honey complexes. Patents have been granted in the USA, Europe, Israel, and Canada. The Extra-C stick utilizes a proprietary process to condense cannabis oil into a toothpick-like matrix, enabling the conversion of regular cigarettes into cannabis or hemp cigarettes.
StickIt operates from facilities in Dalton, Northern Israel, which are central to its research, development, and manufacturing activities. The company’s operating model involves establishing joint ventures in countries where recreational cannabis is permitted. Licensees/joint venture partners will set up production facilities to add cannabis content to sticks produced and supplied by StickIt. StickIt will provide the know-how for manufacturing the finished product. The licensee/joint venture partner will produce the finished product, adding cannabis to the raw materials provided by StickIt, and will sell them either directly to the points of sale or through distributors. The licensee is expected to pay a setup fee by investing the funds necessary to set up the local production facility. Each licensee will have exclusive rights to produce and market Stickit products in their designated territory
Eli Ben-Haroosh, CEO of StickIt Technologies, can be contacted at info@stickit-labs.com for further information.
Contact:
Mr. Eli Ban-Haroosh at info@stickit-labs.com
Source: StickIt Technologies Inc.
